Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622451 · ClinicalTrials.gov registry record · NA
Differential Sensitivity Markers in Youth Drug Abuse Prevention
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02622451: Completed NA study, sponsored by University of Minnesota.
NCT02622451 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02622451, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This pilot study conducts feasibility and exploratory intervention outcome research that will lead to the development of a personalized intervention framework that seeks to preempt the progression from early drug use to more chronic abuse and dependency. The study will explore moderators representing two frameworks, risk severity and differential sensitivity. Moderators will be explored in their ability to influence the differential efficacy of two adolescent drug abuse interventions.
Primary Outcome
Youth Computer Task
Interventions
- BEHAVIORAL Teen Intervene
- BEHAVIORAL Everyday Parenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-12-01 |
| Est. Completion | 2020-03-08 |
| Phase | NA |
What the finished NCT02622451 record still lists
NCT02622451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Teen Intervene is the first listed.
NCT02622451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02622451 about?
NCT02622451 is a clinical study titled "Differential Sensitivity Markers in Youth Drug Abuse Prevention". This pilot study conducts feasibility and exploratory intervention outcome research that will lead to the development of a personalized intervention framework that seeks to preempt the progression from early drug use to more chronic abuse and dependency. The study will explore moderators representin...
What is the current status of trial NCT02622451?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-12-01. Estimated completion is 2020-03-08.
What interventions are being tested in trial NCT02622451?
The interventions under investigation include: Teen Intervene (BEHAVIORAL), Everyday Parenting (BEHAVIORAL).
Who is sponsoring clinical trial NCT02622451?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02622451's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI